Skip to content

A Study on the treatment of post-stroke cognitive impairment with temporal interference transcranial alternating current stimulation based on functional near-infrared spectroscopy analysis

A Study on the treatment of post-stroke cognitive impairment with temporal interference transcranial alternating current stimulation based on functional near-infrared spectroscopy analysis

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400081207
Enrollment
Unknown
Registered
2024-02-26
Start date
2024-03-06
Completion date
Unknown
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

stroke

Interventions

Group A (Group TIS):The patient will receive temporal interference stimulation (TIS) treatment.During treatment, we will adjust the depth and frequency of stimulation based on the patients specific si
Group B (Group tACS):The patient will receiveTranscranial Alternating Current Stimulation (tACS) treatment.The stimulation intensity of this treatment is relatively low, mainly affecting the subcortic

Sponsors

Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: (1) Stroke patients diagnosed through imaging examination (CT/MRI); ? Age = 18 years old and = 85 years old, regardless of gender; (3) No history of brain injury; (4)The Montreal Cognitive Assessment (MoCA) scores range from 15 to 26 points; (5)Primary school education or above, able to recognize and memorize common Chinese characters; (6)Willing to cooperate in completing experimental tasks and sign an informed consent form.

Exclusion criteria

Exclusion criteria: (1) The condition of cerebrovascular disease is progressing; ? Previous history of epilepsy or family history of epilepsy, recent use of antiepileptic drugs; (3)Wearing pacemakers, intracranial metal implants, or having skull defects; (4)Severe heart, liver, kidney diseases, etc., cannot tolerate the test; (5)Having mental illnesses such as depression and schizophrenia; (6)Difficulty in completing tests due to visual and auditory impairments, aphasia, agnosia, and apraxia.

Design outcomes

Primary

MeasureTime frame
Montreal Cognitive Assessment, MoCA;

Secondary

MeasureTime frame
n-back test;Digit Span Test;functional near-infrared spectroscopy, fNIRS;shape trails test;

Countries

China

Contacts

Public ContactCHUNLEI SHAN

Shanghai University of Traditional Chinese Medicine

shanclhappy@163.com+86 138 1621 5058

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026